Annals of internal medicine
-
Randomized Controlled Trial
Brief communication: ramipril markedly improves walking ability in patients with peripheral arterial disease: a randomized trial.
Peripheral arterial disease (PAD) affects up to 12% of adults older than 50 years of age. Conventional therapies have only modest effects in improving symptoms. ⋯ Ramipril improved pain-free and maximum walking time in some adults with symptomatic PAD.